Rivastigmine has 4 known drug interactions based on U.S. FDA drug labeling data. Of these, 4 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Atenolol, Metoclopramide, Oxybutynin. Patients taking Rivastigmine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Contraindicated
- 4
Contraindicated (4)
- Rivastigmine + Atenolol— Additive bradycardic effects may result in syncope. Concomitant use not recommended when signs of bradycardia present.
- Rivastigmine + Metoclopramide— Concomitant use not recommended due to risk of additive extrapyramidal adverse reactions.
- Rivastigmine + Oxybutynin— Rivastigmine may interfere with anticholinergic activity. Concomitant use not recommended unless clinically necessary.
- Rivastigmine + Tolterodine— Rivastigmine may interfere with anticholinergic activity. Concomitant use not recommended unless clinically necessary.